Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 8/20 | 0.40 |
| ▸ | CD69 | Q07108 | 1/20 | 0.33 |
| ▸ | PYGL | P06737 | 3/20 | 0.32 |
| ▸ | PYGM | P11217 | 2/20 | 0.32 |
| ▸ | OGA | O60502 | 1/20 | 0.30 |
| ▸ | GBA1 | P04062 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28126869 | 0.81 | PYGB (0.40) | PYGBPYGLPYGMGBA1GAA | |
| SCHEMBL28554908 | 0.81 | PYGB (0.43) | PYGBCD69PYGLPYGMOGA | |
| SCHEMBL28543896 | 0.80 | PYGB (0.39) | PYGBCD69PYGLPYGM | |
| SCHEMBL27635994 | 0.80 | PYGB (0.39) | PYGBPYGLPYGM | |
| SCHEMBL27352687 | 0.80 | PYGB (0.39) | PYGBCD69PYGLPYGM | |
| SCHEMBL27842967 | 0.74 | PYGB (0.34) | PYGB | |
| SCHEMBL28311665 | 0.74 | PYGB (0.34) | PYGB | |
| SCHEMBL28116306 | 0.74 | PYGB (0.34) | PYGB | |
| SCHEMBL30569120 | 0.73 | PYGB (0.43) | PYGBPYGLPYGMOGAGBA1 | |
| SCHEMBL31598843 | 0.73 | PYGB (0.43) | PYGBPYGLPYGMOGAGBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114934053-B | Fucosyltransferase 8-defective CHO cell line and preparation method and application thereof | 澳斯康生物(南通)股份有限公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-114934053-A | Fucosyltransferase 8-deficient CHO cell line and preparation method and application thereof | 澳斯康生物(南通)股份有限公司 | 2022-08-23 | — | — | CN | disclosed |